UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date: February 27, 2019
Accession Number: 0001144204-19-008163
Submission Type: POS AM
CIK: 0001649989
Company Name: Outlook Therapeutics, Inc.
File Number: 333-209011
Outlook Therapeutics (NASDAQ:OTLK)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Outlook Therapeutics Charts.
Outlook Therapeutics (NASDAQ:OTLK)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Outlook Therapeutics Charts.